(19)
(11) EP 3 213 778 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.03.2023 Bulletin 2023/12

(45) Mention of the grant of the patent:
15.03.2023 Bulletin 2023/11

(21) Application number: 17150192.7

(22) Date of filing: 29.09.2003
(51) International Patent Classification (IPC): 
A61P 17/00(2006.01)
A61L 27/38(2006.01)
C12N 5/00(2006.01)
 A61P 19/00(2006.01)
A61K 35/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61L 27/3804; A61L 27/3839; C12N 5/0068; C12N 2533/54; C12N 2533/90; A61K 35/12; A61P 17/00; A61P 19/00; A61L 2430/10

(54)

CELLS ON A SUPPORT MATRIX FOR TISSUE REPAIR

ZELLEN AUF MATRIXUNTERLAGEN FÜR DIE WIEDERHERSTELLUNG VON GEWEBEN

CELLULES SEMÉES SUR UNE MATRICE DE SUPPORT POUR EFFECTUER DES RÉPARATIONS TISSULAIRES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 27.09.2002 US 414098 P

(43) Date of publication of application:
06.09.2017 Bulletin 2017/36

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03750654.0 / 1546307

(73) Proprietor: Vericel Corporation
Cambridge, MA 02139 (US)

(72) Inventors:
  • MING, Hao Zheng
    City Beach, Western Australia 6015 (AU)
  • GIANNETTI, Bruno
    53347 Bonn (DE)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-01/08610
US-A- 6 120 514
 US-A- 5 306 311
   
  • BONASSAR LAWRENCE J ET AL: "Tissue engineering: The first decade and beyond", JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT, vol. 0, no. 30-31, 1998, pages 297-303, XP009032638, ISSN: 0733-1959
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).